Improving the assessment of quality of life in the clinical care of myeloma patients: the development and validation of the Myeloma Patient Outcome Scale (MyPOS)

by Osborne, Thomas R, Ramsenthaler, Christina, Schey, Stephen A, Siegert, Richard J, Edmonds, Polly M, Higginson, Irene J
Published 2015

The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study

by Ramsenthaler, Christina, Osborne, Thomas R., Gao, Wei, Siegert, Richard J., Edmonds, Polly M., Schey, Stephen A., Higginson, Irene J.
Published 2016

Understanding what matters most to people with multiple myeloma: a qualitative study of views on quality of life

by Osborne, Thomas R, Ramsenthaler, Christina, de Wolf-Linder, Susanne, Schey, Stephen A, Siegert, Richard J, Edmonds, Polly M, Higginson, Irene J
Published 2014

Absence of mutations in cereblon (CRBN) and DNA damage-binding protein 1 (DDB1) genes and significance for IMiD therapy

by Thakurta, A, Gandhi, A K, Waldman, M F, Bjorklund, C, Ning, Y, Mendy, D, Schafer, P, Lopez-Girona, A, Lentzsch, S, Schey, S A, Calle, Y, Chelliah, R, Orlowski, R Z, Madan, A, Avet-Loiseau, H, Chopra, R
Published 2014

Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma

by Dimopoulos, M A, Leleu, X, Palumbo, A, Moreau, P, Delforge, M, Cavo, M, Ludwig, H, Morgan, G J, Davies, F E, Sonneveld, P, Schey, S A, Zweegman, S, Hansson, M, Weisel, K, Mateos, M V, Facon, T, Miguel, J F S
Published 2014